Morningstar

Bausch & Lomb Corp BLCO

Morningstar Rating
Unlock
Stock XNYS Rating as of
$16.87 +0.04 (0.24%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Price vs Fair Value

View History
BLCO is trading at a LOCK|HhQGWD premium.
Price
$16.87
Fair Value
LOCK|.D
Uncertainty
LOCK|H%<
1-Star Price
LOCK|.pm
5-Star Price
LOCK|.y
Economic Moat
LOCK|y@z!
Capital Allocation
LOCK|nw%@#^

Bulls Say, Bears Say

Bulls

Bausch has a strong commercial position in both contact lens and consumer eye care products, and this should drive solid growth over the long term.

Bears

Bausch faces stiff competition across all segments that it plays in, and the lack of investment in its pipeline could leave the firm vulnerable to market share losses.

Show More

News

View All

Trading Information

Previous Close Price
$16.83
Day Range
$16.70–17.05
52-Week Range
$13.61–18.92
Bid/Ask
$16.00 / $17.50
Shares Outstanding
357.17M
Market Cap
$6.03B
Volume/Avg
195,854 / 436,127

Key Statistics

Price/Earnings (Normalized)
65.35
Price/Sales
1.13
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
—

Company Profile

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Growth
Total Number of Employees
13,000
Website
https://www.bausch.com

Competitors

Valuation

View More
Metric
BLCO
ALC
AFX
Price/Earnings (Normalized)
 65.3525.6121.78
Price/Book Value
 0.941.691.29
Price/Sales
 1.133.401.21
Price/Cash Flow
 11.6414.3511.04
Price/Earnings
BLCO
ALC
AFX

Financial Strength

Metric
BLCO
ALC
AFX
Quick Ratio
 0.811.121.40
Current Ratio
 1.552.092.34
Interest Coverage
 0.804.196.98
Quick Ratio
BLCO
ALC
AFX

Profitability

Metric
BLCO
ALC
AFX
Return on Assets (Normalized)
 1.94%5.09%—
Return on Equity (Normalized)
 4.19%7.28%—
Return on Invested Capital (Normalized)
 5.10%7.88%—
Return on Assets
BLCO
ALC
AFX

Medical Instruments & Supplies Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|@!$!$cC<LOCK|pZC$142B
 Becton Dickinson & Co
BDX
LOCK|>!LOCK|BYxNK$49B
 Alcon Inc
ALC
LOCK|BXtRz?>LOCK|!Fvl@$36B
 ResMed Inc
RMD
LOCK|Kk%c>>&RLOCK|d<ZY%$33B
 Medline Inc Ordinary Shares - Class A
MDLN
LOCK|%vy?#bLOCK|l^!Vh$31B
 West Pharmaceutical Services Inc
WST
LOCK|<rC@%LkpLOCK|!xJ$25B
 The Cooper Companies Inc
COO
LOCK|G$GGVPhLOCK|dm?M$15B
 Solventum Corp
SOLV
LOCK|B%fjzf$LOCK|Ng>$14B
 Baxter International Inc
BAX
LOCK|#^LOCK|>$&$#$14B
 Align Technology Inc
ALGN
LOCK|v@V&%<^LOCK|^>>&z$12B

Sponsor Center